The Accelerated Approvals Process: Are Drugmakers Fulfilling Their Promises?
Short Wave
00:00
Navigating the Challenges of Drug Approval Accountability
This chapter examines the complexities and duties involved in the accelerated approvals process for pharmaceuticals, underscoring the need for drugmakers to complete trials for patient benefit. It highlights the implications of withdrawing approvals and stresses the collaborative efforts required between drug manufacturers and regulatory agencies to maintain patient safety and trust.
Transcript
Play full episode
